2 March 2018 - The ABPI has responded to today’s ‘Road to Brexit’ speech by Prime Minister Theresa May.

In today’s speech, the Prime Minister outlined that "UK and EU regulatory standards will remain substantially similar in the future" and that "membership of the European Medicines Agency would mean investment in new innovative medicines continuing in the UK".

Reacting to the speech, Chief Executive of the ABPI, Mike Thompson said:

“Every month, 45 million packs of medicines move from the UK to the EU – and 37 million come the other way. That is why the Prime Minister’s commitment to seek cooperation on medicines regulation would be the best outcome for patients, not just in the UK but across Europe.

Read ABPI press release